13F Filings History of Birchview Capital, LP

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$170,798,560
Signature - Title
Jack Trottier - CFO/CCO
Location
Burlington, VT
Summary
This page shows a list of all the recent 13F filings made by Birchview Capital, LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Birchview Capital, LP reported 68 stock holdings with total value $170,798,560 as of Q4 2025. Top holdings included KLAC, BMY, CMPX, STOK, and LRCX.

Follow Filing Activity

Follow Birchview Capital, LP and return when a new 13F portfolio filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Holdings Value

Sponsored

Quick Takeaways

  • Birchview Capital, LP reports institutional holdings through Form 13F filings.
  • Latest reported quarter: Q4 2025.
  • Latest reported holdings value: $170,798,560.

What Changed

  • Most recent filing was accepted on 13 Feb 2026, 10:19.
  • Reported value moved from $132,446,155 to $170,798,560.

Why This Matters

  • This gives a plain-language read of holdings direction before you open full quarter tables.
  • Use the filing links below to verify the exact SEC source document.

Official SEC Source

Backed by Form 13F

Portfolio holdings and changes are grounded in SEC Form 13F filings.

See Original Filing
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 68 $170,798,560 +$36,470,603 -$15,053,172 +$21,417,431 KLAC, BMY, CMPX, STOK, LRCX 13F-HR 13 Feb 2026, 10:19
Q3 2025 69 $132,446,155 +$21,995,216 -$50,370,058 -$28,374,842 KLAC, BMY, CORT, PRTA, STOK 13F-HR 13 Nov 2025, 15:30
Q2 2025 71 $100,695,689 +$25,150,660 -$22,741,770 +$2,408,890 BMY, KLAC, CORT, OVV, ACAD 13F-HR 14 Aug 2025, 13:43
Q1 2025 68 $115,021,460 +$4,136,001 -$10,955,099 -$6,819,098 BMY, CORT, ACAD, PRTA, BDSX 13F-HR 15 May 2025, 16:48
Q4 2024 68 $122,779,849 $0 $0 $0 BMY, BDSX, ACAD, ELUT, PRTA New Holdings 30 Jun 2025, 11:19
Q4 2024 68 $122,779,849 +$8,257,134 -$3,971,378 +$4,285,756 BMY, BDSX, ACAD, ELUT, PRTA 13F-HR 14 Feb 2025, 13:56
Q3 2024 61 $115,489,427 $0 $0 $0 BMY, BDSX, ACAD, ELUT, UTHR New Holdings 30 Jun 2025, 11:13
Q3 2024 61 $115,489,427 +$7,205,980 -$13,593,718 -$6,387,738 BMY, BDSX, ACAD, ELUT, UTHR 13F-HR 14 Nov 2024, 14:42
Q2 2024 60 $108,192,580 $0 $0 $0 BMY, BDSX, ELUT, NBIX, SILK ROAD MEDICAL INC New Holdings 30 Jun 2025, 11:09
Q2 2024 60 $108,192,580 +$4,050,884 -$9,716,805 -$5,665,921 BMY, BDSX, ELUT, NBIX, SILK 13F-HR 13 Aug 2024, 16:11
Q1 2024 59 $122,695,509 $0 $0 $0 BMY, NBIX, BDSX, ELUT, ACAD New Holdings 30 Jun 2025, 11:03
Q1 2024 59 $122,695,509 +$2,508,417 -$6,773,350 -$4,264,933 BMY, NBIX, BDSX, ELUT, ACAD 13F-HR 14 May 2024, 15:26
Q4 2023 58 $127,809,273 $0 $0 $0 BMY, NBIX, BDSX, ACAD, PRTA New Holdings 30 Jun 2025, 10:46
Q4 2023 58 $127,809,273 +$6,847,387 -$2,260,923 +$4,586,464 BMY, NBIX, BDSX, ACAD, PRTA 13F-HR 13 Feb 2024, 17:58
Q3 2023 51 $117,708,654 $0 $0 $0 BMY, BDSX, NBIX, PRTA, ACAD New Holdings 30 Jun 2025, 10:34
Q3 2023 51 $117,708,654 +$4,734,865 -$16,859,236 -$12,124,371 BMY, BDSX, NBIX, PRTA, ACAD 13F-HR 14 Nov 2023, 15:49
Q2 2023 54 $133,413,992 +$4,834,134 -$766,169 +$4,067,965 BMY, PRTA, NBIX, BDSX, ACAD 13F-HR 08 Aug 2023, 12:23
Q1 2023 55 $127,725,000 +$2,104,899 -$4,406,000 -$2,301,101 BMY, BDSX, NBIX, PRTA, QDEL 13F-HR 12 May 2023, 10:18
Q4 2022 57 $141,566,000 +$9,381,759 -$6,772,174 +$2,609,585 BMY, BDSX, NBIX, PRTA, ELUT 13F-HR 03 Feb 2023, 12:28
Q3 2022 60 $142,011,000 +$2,742,669 -$7,030,251 -$4,287,582 BMY, ELUT, NBIX, PRTA, QDEL Restatement 28 Nov 2022, 13:44
Q2 2022 60 $137,477,000 +$9,779,625 -$7,135,889 +$2,643,736 BMY, ELUT, NBIX, QDEL, FHTX 13F-HR 12 Aug 2022, 08:04
Q1 2022 63 $138,903,000 +$3,429,891 -$5,215,653 -$1,785,762 BMY, NBIX, ELUT, QDEL, ACAD 13F-HR 13 May 2022, 09:54
Q4 2021 67 $155,071,000 +$15,092,907 -$4,846,350 +$10,246,557 BMY, AXDX, ELUT, QDEL, NBIX 13F-HR 14 Feb 2022, 11:43
Q3 2021 64 $146,958,000 +$4,072,529 -$2,844,661 +$1,227,868 BMY, AXDX, BDSX, QDEL, NBIX 13F-HR 12 Nov 2021, 08:43
Q2 2021 62 $165,238,000 +$5,582,711 -$1,020,387 +$4,562,324 BMY, AXDX, BDSX, NBIX, QDEL 13F-HR 10 Aug 2021, 16:57
Q1 2021 54 $168,447,000 +$11,403,277 -$8,542,693 +$2,860,584 BMY, BDSX, AXDX, NBIX, QDEL 13F-HR 14 May 2021, 13:05
Q4 2020 48 $172,816,000 +$32,125,721 -$18,396,993 +$13,728,728 BMY, BDSX, AXDX, QDEL, NBIX 13F-HR 09 Feb 2021, 09:58
Q3 2020 50 $149,674,000 +$3,807,911 -$1,790,514 +$2,017,397 BMY, AXDX, QDEL, AWH, NBIX Restatement 12 Nov 2020, 09:54
Q2 2020 51 $165,457,000 +$23,759,977 -$4,413,429 +$19,346,548 BMY, AXDX, AWH, QDEL, NBIX Restatement 25 Sep 2020, 13:06
Q1 2020 46 $112,738,000 +$14,211,214 -$24,526,010 -$10,314,796 BMY, AXDX, NBIX, QDEL, ACAD 13F-HR 12 May 2020, 11:10
Q4 2019 52 $137,572,000 +$55,803,602 -$74,524,482 -$18,720,880 BMY, AXDX, NBIX, QDEL, OXFD 13F-HR 12 Feb 2020, 15:47
Q3 2019 50 $150,076,000 +$3,662,307 -$9,341,072 -$5,678,765 CELG, AXDX, NBIX, EQM, QDEL 13F-HR 12 Nov 2019, 09:23
Q2 2019 54 $164,429,000 +$6,077,125 -$7,177,657 -$1,100,532 CELG, AXDX, ARRY, NBIX, QDEL 13F-HR 06 Aug 2019, 09:56
Q1 2019 54 $159,600,000 +$4,230,481 -$3,077,817 +$1,152,664 CELG, AXDX, CMTA, NBIX, ARRY 13F-HR 03 May 2019, 13:21
Q4 2018 52 $105,713,000 +$8,596,889 -$4,647,724 +$3,949,165 CELG, AXDX, NBIX, CMTA, ARRY 13F-HR 06 Feb 2019, 06:44
Q3 2018 54 $154,931,000 +$3,364,056 -$6,040,371 -$2,676,315 CELG, AXDX, NBIX, QDEL, VNDA 13F-HR 01 Nov 2018, 15:06
Q2 2018 53 $146,952,000 +$5,413,262 -$7,095,903 -$1,682,641 CELG, AXDX, NBIX, CFRX, QDEL 13F-HR 02 Aug 2018, 13:08
Q1 2018 49 $151,702,000 +$7,934,061 -$6,562,619 +$1,371,442 CELG, AXDX, NBIX, VRML, OXFD 13F-HR 07 May 2018, 14:27
Q4 2017 42 $170,595,000 +$3,698,536 -$2,649,116 +$1,049,420 CELG, AXDX, VRML, NBIX, EQT 13F-HR 02 Feb 2018, 14:08
Q3 2017 40 $193,433,000 +$5,088,751 -$4,693,597 +$395,154 CELG, AXDX, VRML, NBIX, EQT 13F-HR 02 Nov 2017, 15:15
Q2 2017 41 $188,844,000 +$3,586,591 -$13,890,300 -$10,303,709 CELG, AXDX, VRML, EQT, BIOL 13F-HR 08 Aug 2017, 15:29
Q1 2017 41 $179,824,000 +$3,217,122 -$4,843,112 -$1,625,990 CELG, AXDX, VRML, EQT, BIOL 13F-HR 04 May 2017, 12:33
Q4 2016 41 $162,502,000 +$1,041,625 -$1,679,029 -$637,404 CELG, AXDX, EQT, VRML, MASI 13F-HR 09 Feb 2017, 15:45
Q3 2016 43 $171,332,000 +$2,538,231 -$4,313,868 -$1,775,637 CELG, AXDX, VRML, EQT, BIOL 13F-HR 14 Nov 2016, 15:22
Q2 2016 45 $137,756,000 +$1,063,036 -$1,447,133 -$384,097 CELG, AXDX, EQT, VRML, HNSN 13F-HR 09 Aug 2016, 15:57
Q1 2016 40 $140,261,000 +$2,165,890 -$2,175,625 -$9,735 CELG, AXDX, VRML, MBLX, EQT 13F-HR 28 Apr 2016, 16:00
Q4 2015 40 $173,676,000 +$5,737,948 -$7,454,089 -$1,716,141 CELG, AXDX, VRML, MBLX, CFRX 13F-HR 08 Feb 2016, 15:06
Q3 2015 42 $155,389,000 +$9,659,684 -$19,219,578 -$9,559,894 CELG, AXDX, VRML, MBLX, EQT Restatement 30 Dec 2015, 14:40
Q2 2015 41 $189,286,000 +$7,275,119 -$49,596,177 -$42,321,058 CELG, AXDX, MBLX, VRML, HNSN Restatement 17 Aug 2015, 10:18
Q1 2015 38 $190,344,000 +$6,886,643 -$2,913,723 +$3,972,920 CELG, AXDX, MBLX, VRML, EQT Restatement 07 May 2015, 14:42
Q4 2014 33 $172,249,000 $0 $0 $0 CELG, AXDX, VRML, MBLX, EQT Restatement 07 May 2015, 13:24